Boehringer Ingelheim contest seeks COPD songs

Share this article:
Boehringer Ingelheim contest seeks COPD songs
Boehringer Ingelheim contest seeks COPD songs
Boehringer Ingelheim is partnering with the Country Music Association for a Tune Up For COPD Songwriting Competition featuring country music stars Billy Ray Cyrus and Patty Loveless.

The contest is soliciting “songs with a motivational message that encourages people to be proactive in taking control of their lives and be healthy,” and the winner will perform it live at the CMA Music Festival in Nashville in June. Contestants can upload their videos and lyrics sheets to tuneup4copd.cmaworld.com, and a “fan favorite” will be determined by the highest number of online votes and showcased online. The overall winner will be selected by a panel of judges including Cyrus, Loveless, industry experts and members of participating organizations including the American Association for Respiratory Care, Country Music Association, COPD Alliance, COPD Foundation, NASCAR and US COPD Coalition.

Cyrus is the newest celebrity addition to Boehringer Ingelheim's COPD awareness efforts, which have also featured Jim Belushi, driver Danica Patrick and football star Michael Strahan. Cyrus's grandfather, a pastor, suffered from COPD. Loveless last year penned the song Drive for the company's Drive4COPD campaign, honoring her sister Dottie, who died of COPD at age 48.

COPD, which includes chronic bronchitis and emphysema, affects an estimated 24 million Americans. Boehringer Ingelheim's COPD products include Spiriva, Combivent, Atrovent and Berodual/Bronchodual/Duovent.
Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.